Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease.

Journal article

Wellens J. et al, (2022), Lancet Gastroenterol Hepatol

Systemic Inflammation in Preclinical Ulcerative Colitis.

Journal article

Bergemalm D. et al, (2021), Gastroenterology, 161, 1526 - 1539.e9

SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy.

Journal article

Selim R. et al, (2021), Lancet Gastroenterol Hepatol

Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 2021.

Journal article

Gupta V. et al, (2021), J Crohns Colitis, 15, 1211 - 1221

Reply

Journal article

Nowak JK. et al, (2021), Gastroenterology, 160, 2622 - 2623

Load More